Revision within 5 years

Shoulder » Survival » Revision within 5 years » By type of shoulder arthroplasty

FIGURE Cumulative revision percentage of primary shoulder arthroplasties by type of shoulder arthroplasty in the Netherlands in 2014-2019 (n=16,309)

S30 afbeelding.png

TABLE Cumulative 5-years revision percentage

Type of primary shoulder arthroplasty Cumulative 5-year revision percentage
Number (n) Competing Risk¹ (95% CI) Kaplan Meier (95% CI)
Reverse 10,782 4.4 (3.9-4.9) 4.7 (4.1-5.2)
Total anatomical  3,587 5.8 (4.8-7.0) 5.9 (4.8-7.1)
Hemi 1,940 11.3 (9.6-13.1) 11.9 (10.0-13.7)

¹ The cumulative revision percentage using the competing risk method is shown in the figure.
Please note: Dotted lines represent the upper and lower limits of the 95% confidence interval.
Reverse: reverse total shoulder arthroplasty; Total anatomical: total anatomical shoulder arthroplasty; Hemi: shoulder hemiarthroplasty. CI: confidence interval

© LROI 2020

Shoulder » Survival » Revision within 5 years » Reverse total shoulder arthroplasty by demographics

TABLE Cumulative 5-year revision percentages of primary reverse total shoulder arthroplasties by demographics in the Netherlands in 2014-2019

Cumulative 5-year revision percentage
  Number (n) Competing Risk (95% CI) Kaplan Meier (95% CI)
Total 10,782 4.4 (3.9-4.9) 4.7 (4.1-5.2)
Gender
   Men 2,478 8.9 (7.5-10.4) 9.4 (7.8-10.9)
   Women 8,293 3.1 (2.6-3.7) 3.3 (2.8-3.9)
Age (years)
   <50 83 n.a. n.a.
   50-59 365 n.a. n.a.
   60-69 2,300 7.0 (5.7-8.6) 7.3 (5.8-8.7)
   70-79 5,454 4.0 (4.4-4.8) 4.3 (3.5-5.0)
   ≥80 2,568 2.2 (1.7-2.9) 2.4 (1.7-3.0)
Diagnosis
   Osteoarthritis 3,276 3.9 (3.1-4.9) 4.2 (3.2-5.1)
   Other 7,477 4.8 (4.1-5.6) 4.9 (4.2-5.6)
ASA score
   I 583 8.5 (5.4-13.4) 8.8 (4.9-12.6)
   II 6,334 3.7 (3.2-4.4) 3.9 (3.3-4.5)
   III-IV 3,707 4.8 (3.9-5.8) 5.2 (4.2-6.2)
Walch score
   A1 4,970 4.5 (3.8-5.3) 4.7 (3.9-5.5)
   A2 2,289 4.5 (3.5-5.9) 4.8 (3.5-6.0)
   B1 993 3.4 (2.3-5.0) 3.4 (2.1-4.7)
   B2 555 n.a. n.a.
   B3 183 n.a. n.a.
   C
Body Mass Index (kg/m²)
  Underweight (≤18,5) 109 n.a. n.a.
  Normal weight (>18,5-25) 3,017 4.0 (3.1-5.2) 4.3 (3.2-5.5)
  Overweight (>25-30) 4,192 4.2 (3.5-5.1) 4.5 (3.7-5.3)
  Obesity (>30-40) 3,008 4.8 (3.9-5.8) 4.9 (3.9-5.9)
  Morbid obesity (>40) 292 n.a. n.a.
Smoking
  No 9,467 4.3 (3.8-4.9) 4.5 (3.9-5.1)
  Yes 404 5.6 (4.2-7.4) 5.8 (4.2-7.3)

Please note: n.a. if <50 cases were at risk; CI: confidence interval.

© LROI 2020

Shoulder » Survival » Revision within 5 years » Total anatomical shoulder arthroplasty by demographics

TABLE Cumulative 5-year revision percentages of primary total anatomical shoulder arthroplasties by demographics in the Netherlands in 2014-2019

Cumulative 5-year revision percentage
  Number (n) Competing Risk (95% CI) Kaplan Meier (95% CI)
Total 3,587 5.8 (4.8-7.0) 5.9 (4.8-7.1)
Gender
   Men 1,065 5.9 (4.3-8.0) 5.9 (4.1-7.8)
   Women 2,518 5.8 (4.6-7.3) 5.9 (4.5-7.3)
Age (years)
   <50 204 n.a. n.a.
   50-59 622 9.5 (6.5-13.9) 9.7 (6.0-13.3)
   60-69 1,383 5.7 (4.4-7.5) 5.8 (4.2-7.4)
   70-79 1,093 4.1 (2.6-6.6) 4.2 (2.2-6.3)
   ≥80 282 n.a. n.a.
Diagnosis
   Osteoarthritis 2,971 5.2 (4.2-6.6) 5.3 (4.1-6.6)
   Other 602 9.8 (7.0-13.8) 8.9 (6.0-11.7)
ASA score
   I 512 8.1 (5.2-12.8) 7.9 (4.4-11.4)
   II 2,365 5.9 (4.7-7.4) 6.0 (4.6-7.4)
   III-IV 667 4.0 (2.5-6.4) 3.9 (2.0-5.8)
Walch score
   A1 1,453 6.6 (5.0-8.5) 6.7 (4.9-8.4)
   A2 1,006 5.9 (4.2-8.3) 6.0 (3.9-8.0)
   B1 575 3.5 (2.0-5.9) 3.5 (1.6-5.4)
   B2 241 n.a. n.a.
   B3 45 n.a. n.a.
   C 14 n.a. n.a.
Body Mass Index (kg/m²)
  Underweight (≤18,5) 16 n.a.  n.a.
  Normal weight (>18,5-25) 873 5.8 (4.0-8.6) 6.0 (3.6-8.3)
  Overweight (>25-30) 1,393 4.5 (3.4-6.1) 4.6 (3.2-6.0)
  Obesity (>30-40) 1,128 7.8 (5.7-10.8) 8.0 (5.4-10.6)
  Morbid obesity (>40) 108 n.a.  n.a.
Smoking
   No 3,099 5.3 (4.3-6.6) 5.4 (4.2-6.5)
   Yes 429 7.9 (5.1-12.2) 8.2 (4.6-11.9)

Please note: n.a. if <50 cases were at risk; CI: confidence interval.

© LROI 2020